ACTIVE

MY®HEALTH

Financial year 2025 · Closed on 31/12/2025

Net result152,1 k €+46,7 %over 1 year
Gross margin1,6 M €+22,2 %over 1 year
Equity612,8 k €+26,0 %over 1 year
Workforce12,2 ETP+16,2 %over 1 year

Identity

Source · BCE/KBO

MY®HEALTH is a Public limited company incorporated in 2017. Its main activity is: Manufacture of basic pharmaceutical products. Its registered office is in Lummen. It employs on average 12,2 ETP workers (FTE).

Legal situation
Normal situation
BCE/KBO no. / VAT
BE 0682.509.420
Incorporation
04/10/2017
Legal form
Public limited company
Registered office
Lindekensveld 7
3560 Lummen · FlandreSee on map
Contributed capital
200 000,00 €
Latest accounts
31/12/2025
Average workforce
12,2 ETP
Joint committees (1)
  • 207
Contacts
2 public details availableLog in to view
Signals
ProfitableLow riskGood liquidityPositive cashflowPositive EBITDAHealthy social debts

Financials

Source · NBB, 8 filings

Trend over 6 financial years

20252024202320222021
Income statement
Gross margin1,6 M €1,3 M €1 M €938,9 k €768,4 k €
EBITDA245,9 k €202,4 k €149,2 k €125,8 k €120,6 k €
Operating result232,7 k €192,7 k €144,5 k €121,9 k €117,9 k €
Net result152,1 k €103,7 k €105,8 k €71,1 k €64,1 k €
Balance sheet
Equity612,8 k €486,5 k €382,8 k €347 k €275,9 k €
Total assets2,6 M €2,2 M €1,7 M €1,6 M €1,1 M €
Cash29,7 k €144,2 k €157,9 k €121,5 k €172,5 k €
Debts1,5 M €1,1 M €1,2 M €943,8 k €792,5 k €
Other
Workforce12,2 ETP10,5 ETP8,9 ETP8,8 ETP7,5 ETP

Valuation

Indicative valuation

As an indication, this company is worth

between 500 k€ and 1 M€
See the valuation

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Biocodex SAS

Director · since 16 janvier 2024 · until 01 juin 2029

Represented by Nicolas COUDURIER

Active
Dybacon

Managing director · since 26 septembre 2023 · until 26 septembre 2029 · 0668.689.591

Represented by Raf Dybajlo

Active
Joske Dexters

Director · since 26 septembre 2023 · until 26 septembre 2029

Active

Ended mandates

Biocodex

Director · since 16 janvier 2024 · until 01 juin 2029

Represented by Nicolas COUDURIER

Ended
Dybacon

Managing director · since 26 septembre 2023 · until 26 septembre 2029 · 0668.689.591

Represented by Raf DYBAJLO

Ended
Dybacon

Managing director · since 04 octobre 2017 · until 02 juin 2023 · 0668.689.591

Represented by Raf DYBAJLO

Ended
Dybacon

Managing director · since 04 octobre 2017 · until 04 octobre 2023 · 0668.689.591

Represented by Raf Dybajlo

Ended

Other companies at this address

Lindekensveld 7 3560 Lummen
CompanyCBE no.
0684.959.659
MY HOLDING● Active
1003.694.038

Full financial information

Source · NBB
202520242023202220212020
Type of accountAbridged modelAbridged modelAbridged modelAbridged modelAbridged modelAbridged model
Start of the financial year01/01/202501/01/202401/01/202301/01/202201/01/202101/01/2020
Closing of the financial year31/12/202531/12/202431/12/202331/12/202231/12/202131/12/2020
Length of the financial year12 months12 months12 months12 months12 months12 months
Filing date19/06/202625/07/202529/07/202403/08/202331/07/202219/02/2021
General meeting05/06/202630/06/202507/06/202402/06/202330/06/202210/02/2021
Currency of the financial yearEUREUREUREUREUREUR
NBB quality labelSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controlsSatisfying controls

Financial ratios

Source · NBB

Looking for more information about this company?

Try for free

Annual accounts filings

Source · NBB, 8 filings
ModelClosingGeneral meetingFiledLanguageDocument
Abridged model31/12/202505/06/202619/06/2026DutchPDF
Abridged model31/12/202430/06/202525/07/2025DutchPDF
Abridged model31/12/202307/06/202429/07/2024DutchPDF
Abridged model31/12/202202/06/202303/08/2023DutchPDF
Abridged model31/12/202130/06/202231/07/2022DutchPDF
Abridged model31/12/202010/02/202119/02/2021DutchPDF
Abridged model31/12/201924/06/202030/07/2020DutchPDF
Abridged model31/12/201828/06/201929/08/2019DutchPDF

Indicative valuation

Order of magnitude

As an indication, this company is worth

between 500 k€ and 1 M€

The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.

Discover the Business plan
Disclaimer

Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.

Board of directors

Source · NBB, accounts to 31/12/2025

3 active · 8 ended

Active mandates

Biocodex SAS

Director · since 16 janvier 2024 · until 01 juin 2029

Represented by Nicolas COUDURIER

Active
Dybacon

Managing director · since 26 septembre 2023 · until 26 septembre 2029 · 0668.689.591

Represented by Raf Dybajlo

Active
Joske Dexters

Director · since 26 septembre 2023 · until 26 septembre 2029

Active

Ended mandates

Biocodex

Director · since 16 janvier 2024 · until 01 juin 2029

Represented by Nicolas COUDURIER

Ended
Dybacon

Managing director · since 26 septembre 2023 · until 26 septembre 2029 · 0668.689.591

Represented by Raf DYBAJLO

Ended
Dybacon

Managing director · since 04 octobre 2017 · until 02 juin 2023 · 0668.689.591

Represented by Raf DYBAJLO

Ended
Dybacon

Managing director · since 04 octobre 2017 · until 04 octobre 2023 · 0668.689.591

Represented by Raf Dybajlo

Ended

Ownership and network

Looking for more information about this company?

Try for free

Belgian Official Gazette publications

Source · Belgian Official Gazette
  • Mandates02/02/2024
    MAATSCHAPPELIJKE ZETEL - ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares12/01/2024
    KAPITAAL - AANDELEN
    PDF
  • Mandates29/12/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Mandates05/10/2023
    ONTSLAGEN - BENOEMINGEN
    PDF
  • Capital / shares15/07/2019
    STATUTEN (VERTALING, COÖRDINATIE, OVERIGE WIJZIGINGEN, …) - KAPITAAL - AANDELEN
    PDF
  • Other06/10/2017
    RUBRIEK OPRICHTING (NIEUWE RECHTSPERSOON, OPENING BIJKANTOOR, ENZ...)
    PDF

Similar companies

A company's peers, by sector and size, are included in the Business plan.

See the Business plan

Timeline

  1. 2025
    Annual accounts 2025152,1 k €↑
  2. 2024
    Annual accounts 2024103,7 k €↓
  3. 2023
    Annual accounts 2023105,8 k €↑
  4. 2022
    Annual accounts 202271,1 k €↑
  5. 2021
    Annual accounts 202164,1 k €↑
  6. 2018
    Annual accounts 2018-174,5 k €
  7. 04/10/2017
    IncorporationPublic limited company